Arterra Bioscience SpA (MIL:ARBS) Payments of Debt: €-0.10 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:ARBS Arterra Bioscience SpA MIL:ARBS
83 GF Score
Price €3.19
GF Value €2.92
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Arterra Bioscience SpA Payments of Debt?

Arterra Bioscience SpA MIL:ARBS +1.59% 83 Payments of Debt is €-0.10 Mil as of Dec. 2025. GuruFocus rates MIL:ARBS with a GF Score™ of 83/100 and a GF Value™ of €2.92 (Fairly Valued). The stock has 1 warning sign investors should review.

Arterra Bioscience SpA's Payments of Debt for the six months ended in Dec. 2025 was €-0.05 Mil.

Arterra Bioscience SpA's Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.10 Mil.

Arterra Bioscience SpA Payments of Debt Related Terms

Arterra Bioscience SpA Payments of Debt Historical Data

* Premium members only.

The historical data trend for Arterra Bioscience SpA's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arterra Bioscience SpA Payments of Debt Chart

Arterra Bioscience SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
Get a 7-Day Free Trial Premium Member Only -0.20 -0.13 -0.20 -0.06 -0.10

Arterra Bioscience SpA Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.18 0.00 -0.06 -0.05 -0.05
MIL:ARBS
83GF Score
Arterra Bioscience SpA MIL:ARBS
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arterra Bioscience SpA Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of €-0.10 Mil mean?
Arterra Bioscience SpA (MIL:ARBS) has a Payments of Debt of €-0.10 Mil as of Dec. 2025. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Arterra Bioscience SpA and its competitors.
Is Arterra Bioscience SpA's Payments of Debt too high?
Arterra Bioscience SpA's current Payments of Debt is €-0.10 Mil. Overall, Arterra Bioscience SpA has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Arterra Bioscience SpA's Payments of Debt compare to VRTX and REGN?
Arterra Bioscience SpA's Payments of Debt of €-0.10 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Arterra Bioscience SpA and its competitors. Arterra Bioscience SpA's current Payments of Debt is €-0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arterra Bioscience SpA stock overvalued right now?
Based on GuruFocus' analysis, Arterra Bioscience SpA (MIL:ARBS) is currently considered Fairly Valued. The stock's GF Value™ is €2.92, compared to a current price of €3.19 — trading 9.2% above its estimated fair value. The current Payments of Debt is €-0.10 Mil. Arterra Bioscience SpA's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Arterra Bioscience SpA (MIL:ARBS), the current Payments of Debt is €-0.10 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arterra Bioscience SpA (MIL:ARBS) Overvalued in 2026?

Based on GuruFocus' analysis, Arterra Bioscience SpA stock appears to be overvalued. The current stock price of €3.19 is trading 9.2% above its estimated GF Value™ of €2.92. GuruFocus considers Arterra Bioscience SpA to be Fairly Valued.

Key valuation signals for MIL:ARBS:

  • Payments of Debt: €-0.10 Mil
  • GF Value™: €2.92 vs. price of €3.19 (9.2% above fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the MIL:ARBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arterra Bioscience SpA Business Description

Address via Benedetto Brin, 69, Napoli, ITA, 80142
Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.
83GF Score

Get the complete analysis for MIL:ARBS

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.19
Price
€2.92
GF Value